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Abstract:  
Carbon nanotubes (CNT) cytotoxicity is frequently investigated using in vitro classical 
toxicology assays. However these cellular tests, usually based on the use of colorimetric or 
fluorimetric dyes, were designed for chemicals and may not be suitable to nano-sized 
materials. Indeed, due to their unique physico-chemical properties CNT can interfere with 
the assays and bias the results. To get accurate data and draw reliable conclusions, these 
artifacts should be carefully taken into account. The aim of this study was to evaluate 
qualitatively and quantitatively the interferences occurring between CNT and the commonly 
used lactate dehydrogenase (LDH) assay. Experiments in cell free conditions were 
performed and it was clearly demonstrated that artifacts occurred. They were due to the 
intrinsic absorbance of CNT on one hand and to the adsorption of LDH at the CNT surface 
on the other hand. The adsorption of LDH on CNT was modeled and was found to fit the 
Langmuir model. The Kads and neq constants were defined, allowing the correction of results 
obtained from cellular experiments to get more accurate data and lead to proper conclusions 
on the cytotoxicity of CNT. 
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Introduction: 
The use of nanomaterials in general and of carbon nanotubes (CNT) in particular has 
incredibly increased during the last decades. Due to their exceptional physico-chemical 
properties CNT exhibit promising applications, in fields as varied as material sciences, 
microelectronics and even medicine1,2… This extensive use results in an increased risk of 
exposure for workers and consumers therefore leading to a growing need for accurate 
cytotoxicity assays. For that purpose in vitro cellular assays are usually used. Although 
insufficient to draw firm conclusions they are useful for a rapid screening of the cellular 
response in terms of cytotoxicity, pro-inflammatory effect, oxidative stress, genotoxicity… 
but only if they are conducted properly. Indeed, in nanotoxicological studies, standard 
toxicological assays are used but these latter were developed for chemicals and they may not 
be suitable for these particular nanomaterials3–5. These assays use colorimetric or fluorimetric 
dyes as markers to determine cell viability assessing membrane integrity or cell metabolism. 
Due to their high surface area, nanomaterials can interfere with the assay components or 
products and bias the results, potentially leading to misinterpretations. Besides, this has been 
proposed as a partial explanation for the conflicting results reported in the literature about 
the cytotoxicity of nanomaterials6 and especially CNT. 
For example, Wörle-Knirsch et al.7 have demonstrated that CNT could trigger false-positive 
results with one of the most popular cytotoxicity assay: the MTT test. This assay is based on 
the conversion of a yellow tetrazolium salt: the MTT [3-(4,5-Dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide] into an insoluble purple formazan precipitate. This 
reduction is carried out by the mitochondria of viable cells and therefore the amount of 
formazan formed (quantified by measuring the absorbance at 570 nm) is directly 
proportional to cell viability. CNT have been shown to interact with the tetrazolium salts 
used in this test (but not with that used in variants of this assays such as the WST-1, INT or 
XTT assays)7 making impossible the MTT conversion into formazan. This interference was 
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confirmed by Belyanskaya et al.8 and Casey et al.9 further demonstrated that CNT interacted, 
with a variable degree, with all the cell viability dyes they used in their study (i.e. 
Commassie Blue, Alamar Blue, Neutral Red, MTT and WST-1), arguing for the inadequacy of 
these assays to report CNT cytotoxicity. Similarly, Monteiro-Riviere et al.10 tested a panel of 
six classical dye-based assays and found that most of them produced erroneous results. 
Similarly, it was observed that nanomaterials could interfere with classical genotoxicity 
assays (micronucleus or comet assays), oxidative stress assay (measurement of reactive 
oxygen species), or with inflammatory response assays (evaluation of the production of 
various cytokines or mediators)11–15. As an example, a previous study from our group 
focused on the artifacts occurring during the assessment of TNF production after a contact 
between macrophages and boehmite nanoparticles16. It was observed that 6 wt.% of TNF 
adsorbed on the walls of 96-well plates, and 13 wt.% adsorbed on the boehmite surface. This 
suggests that data from this assay can be underestimated. 
The interference in biological assays are far from being systematically taken into 
consideration, as reported by Ong et al.6. In this paper a review of the existing 
nanotoxicology literature was carried out to assess whether appropriate assay controls were 
performed to ensure that nanomaterials did not interfere with the assays and that the results 
of these tests were accurate. It turned out that in 2010, 84% of papers in the nanotoxicology 
field used at least one type of colorimetric or fluorescence assay and of these, 95% were 
published without reporting controls for nanomaterial interferences. In 2012, 
notwithstanding the increasing number of published reports on nanomaterial-assay 
interferences, this rate had only marginally improved: 90% of papers were published 
without some type of assay control. This may explain the lack of consistency of some results 
reported in the literature. 
These interferences may be so important that they can make some commonly used tests 
totally irrelevant to report nanomaterials toxicity7,9,8,17. But as the nature and intensity of 
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artifacts also depend on the nanomaterial type, many authors recommend that interferences 
should be carefully assessed for each nanomaterial type in an acellular system. In other 
words, the suitability of the assay for assessing nanomaterial toxicity should be examined 
case by case. Only this approach will allow selecting the optimal assay for different types of 
nanomaterials4,10,18. 
In this context, we focused our attention on the cytotoxicity of CNT, in particular the loss of 
membrane integrity was evaluated by the commonly used released lactate dehydrogenase 
(LDH) quantification. The principle of this toxicological assay is illustrated in Figure 1.  
 
 
Figure 1: Schematic representation of the principle of the LDH release assay. The LDH assay 
evaluates the membrane integrity of cells by measuring the concentration of the cytosolic 
LDH enzyme leaked in the extracellular medium in case of membrane damage. 
 
Briefly, the LDH released from cells in the culture supernatant catalyzes the hydrolysis of 
lactate in pyruvate. This reaction is accompanied by the stoichiometrical reduction of 
Nicotinamide Adenine Dinucleotide (NAD+) in NADH. This latter is used as a limiting 
reagent in a second reaction catalyzed by the diaphorase. A tetrazolium salt: INT (2-(4-
iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tertrazolium) is transformed in red formazan 
which formation can be spectrophotometrically quantified at 490 nm and which amount is 
proportional to that of LDH present in the medium. But in this assay, artifacts can be due to 
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three parameters: 1) the CNT intrinsic absorbance, 2) the interactions between CNT and 
reagents from the assay or 3) the interactions between CNT and LDH. 
The aim of this study was to evaluate qualitatively and quantitatively the interferences 
occurring between the CNT and the LDH assay. To that purpose, experiments in cell free 
conditions were performed, and from the data obtained the adsorption isotherm of LDH on 
CNT was studied. This allowed taking into account the interferences occurring in the assay 
and consequently correcting results from cellular experiments to get more accurate data and 
lead to proper conclusions on the cytotoxicity of CNT. 
  
Experimental:  
 CNT: 
Multi-walled carbon nanotubes (MWCNT, NC7000) were provided by Nanocyl (Sambreville, 
Belgium). They measured 9.5 nm in diameter and 1.5 µm in length (according to the 
manufacturer). CNT were dispersed in culture medium: Dubelcco’s modified Eagle’s 
medium (DMEM, Invitrogen) complemented with 10%fetal calf serum (FCS, Invitrogen), 1% 
penicillin-streptomycin (penicillin 10,000 U.mL-1, streptomycin 10 mg.mL-1, Sigma-Aldrich). 
Concentrations from 15 to 120 µg.mL-1 were used. A sonication was carried out until the 
complete dispersion of the suspension (5 min, 30 %, 3 mm probe, Branson Sonifier S-450D). 
The dispersion and suspension stability were established by measuring zeta potential and 
particle size distribution by means of the light scattering technique (Zetasier Nano ZS). After 
dilutions, the suspensions were kept at 4°C and used in the following 48 h.  
 LDH assay in cell free conditions: 
The LDH assay was performed using the CytoTox-96 non-radioactive cytotoxicity assay kit 
(Promega). Within this kit a LDH solution was provided as a positive control solution. This 
LDH was extracted from bovine heart and its initial concentration was 0.8 U.µL-1. U is the 
unit of enzymatic activity, defining the speed of consumption of a substrate by unit of time. 
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For example, in the LDH case, 1U corresponds to the oxidation of 1 mM.min-1 of NADH. A 
protocol to assess the interferences in the determination of the LDH release was established 
in cell free conditions. The absorbance of solutions containing LDH alone (concentrations 
from 0.00005 to 0.004 U.µL-1), CNT alone (concentrations from 15 to 120 µg.mL-1) or a mixture 
of LDH and CNT was assessed using a microplate reader (Multiskan GO, Thermo Scientific) 
set at 450 nm. Negative controls were also included (solutions with no LDH or no CNT). 
 LDH assay in cellular conditions: 
The RAW264.7 cell line, commonly used in nanotoxicology studies was provided by ATCC 
Cell Biology Collection (Promochem LGC) and derived from mice peritoneal macrophages 
transformed by AMLV (Abelson Murine Leukemia Virus). Cells were cultured in 
complemented DMEM and incubated at 37°C under a 5% carbon dioxide humidified 
atmosphere. Cells were seeded in a 96-well plate (100,000 cells/well) and were incubated for 
24h with CNT (concentration ranging from 15 to 120 µg.mL-1). Cell viability was then 
evaluated by quantifying the LDH released in culture supernatant from cells with damaged 
membranes, using the CytoTox-96 non-radioactive cytotoxicity assay according to the 
manufacturer’s instructions. Detection was performed using a microplate reader (Multiskan 
GO, Thermo Scientific) at 450 nm. The activity of the released LDH was reported as a 
percentage of the total cellular LDH (measured after the complete lysis of control cells 
corresponding at the maximal amount that can be released by cells, therefore 100%). 
 Expression of the results and statistical analysis: 
Results are expressed as means of 3 independent experiments, with each measure performed 
in triplicate. Statistical analysis was carried out using a Student test. Difference was declared 
significant when p<0.05. 
 
Results:  
 Cell free condition assays: 
8 
 
The absorbance at 450 nm of solutions containing various concentrations of LDH (from 0 to 
0.004 U.µL-1) was measured in presence of various concentrations of CNT (from 0 to 120 
µg.mL-1). Results are reported in Figure 2. 
 
Figure 2: Absorbance at 450 nm of solutions containing CNT and LDH (acellular condition). * 
p<0.05 as determined by a Student test. 
 
It clearly appeared that CNT alone induced a dose-dependent increase in absorbance at 450 
nm. The addition of low doses of LDH (0.00005 or 0.0005 U.µL-1) did not influence this 
increase. But with higher concentrations of LDH (0.001 or 0.004 U.µL-1) a peculiar behavior 
was observed: solutions containing 30 or 60 µg.mL-1 CNT exhibited an absorbance 
significantly lower than that containing 15 or 120 µg.mL-1 and even than that without CNT. 
From these observations three assumptions could be made: 
* *
*
*
*
*
*
*
*
0
0.5
1
1.5
2
2.5
0 0.00005 0.0005 0.001 0.004
Absorbance
(450 nm)
LDH concentration (U.µL-1)
No CNT
[CNT] = 15 µg.mL⁻¹ 
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1. An optical artifact occurred, induced by the partial extinction of light due to the diffusing 
nature of CNT.  
2. An artifact due to a variation of the LDH concentration consecutive to its adsorption at 
the CNT surface might be implicated. 
3. A combination of the two above-mentioned artifacts occurred. 
 
To test the first hypothesis, the absorbance of CNT alone was further investigated. CNT were 
diluted either in PBS (Phosphate Buffered Saline) or in culture medium in presence of the 
reagents from the assay, and the absorbance was measured as indicated in Figure 3. 
  
Figure 3: Absorbance at 450 nm of CNT diluted in culture medium in presence of the kit 
reagents or diluted in an equivalent volume of PBS. 
 
An intrinsic dose-dependent absorbance of CNT was clearly observed when CNT were 
diluted in PBS. At the lowest CNT concentrations, a slight additive absorbance was due to 
y = 0.005x + 0.2999
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the culture medium and the assay kit reagents. This result clearly demonstrated an optical 
artifact due to the presence of CNT. 
 
 Quantification of the interferences: 
The intrinsic ability of CNT to interfere with the LDH assay through their diffusive nature 
can thus lead to biased measures. Indeed, CNT can diffuse the incident light and induce a 
partial extinction of the signal. The evolution of the absorbance only due to the presence of 
CNT at low concentrations (without the presence of LDH) follows a linear relationship, 
respecting the Beer-Lambert law:  
      Equation 1 
where A represents the absorbance, ε the molar extinction coefficient (L.mol-1.cm-1), l the 
length of the optical path travelled by the light beam (cm) and C the concentration (mol.L-1). 
Similarly, the absorbance of LDH alone follows a linear relationship (y = 942.1x + 0.3239; 
R²=0.9997, see Supplementary Figure 1).  
In theory, the absorbance of a mixture of two solutions is equivalent to the sum of the 
absorbance of each solution. In other words, we should observe that ACNT+LDH = ALDH + ACNT. 
However, this was not the case: the absorbance of the solution containing both CNT and a 
known concentration of LDH was lower than that of the control solution containing only 
LDH, without CNT. An example (for the 0.001 U.µL-1 LDH concentration) is detailed in 
Figure 4 but the same conclusion was reached for each LDH concentration as reported in 
Supplementary Figure 2. 
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Figure 4: Difference between the theoretical and experimental absorbance of a LDH solution 
(concentrated 0.001 U.µL-1) with various concentrations of CNT.  
 
This may suggest that between the assumptions previously made on the nature of the 
interferences (optical artifact induced by the partial extinction of light due to the diffusing 
nature of CNT or an artifact due to a variation of the LDH concentration consecutive to its 
adsorption at the CNT surface), the two occurred simultaneously. A part of the LDH initially 
introduced in the solution absorbed at the CNT surface, thus decreasing the amount of free 
LDH available to catalyze the conversion of lactate in pyruvate and therefore decreasing the 
amount of formed INT formazan.    
From this hypothesis and based on the absorbance of the CNT and LDH solutions measured 
either separately or in mixture, it was possible to calculate the amount of LDH free in 
solution depending on the CNT concentration as determined by the following equation and 
as reported by Figure 5A. 
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Equation 2 
where free LDH represents the amount of LDH free in solution (mol), theoretic LDH is the theoretic 
amount of LDH in solution (i.e. the introduced amount of LDH, in mol), theoretic LDH is the 
awaited absorbance of the LDH solution (calculated by the Beer-Lambert law, Equation 1), 
ALDH+CNT the measured absorbance of the solution containing both LDH and CNT and ACNT 
the absorbance of the solution with CNT only.  
The amount of LDH adsorbed on the CNT can then be deduced simply by subtracting the 
amount of LDH free in solution (and that has formed the colored INT formazan) from the 
initially introduced LDH, as reported in Figure 5B.  
A) 
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Figure 5: A) Free LDH depending on the CNT concentration calculated for different LDH 
concentrations (concentration from 0.00005 to 0.004 U.µL-1). B) LDH adsorbed on CNT 
calculated for different LDH concentrations (concentration from 0.00005 to 0.004 U.µL-1). 
 
The thermodynamic equilibrium was reached leading to the determination of the adsorption 
isotherm. Figure 6 represents this adsorption isotherm, i.e. the amount of adsorbed LDH by 
mass of CNT depending on the amount of free LDH reported by mass of CNT. The same 
conclusion was reached when the data were expressed depending on CNT surface instead of 
CNT mass (Supplementary Figure 3). The results confirmed the existence of a bias due to the 
adsorption of LDH on CNT, providing an explanation for the difference observed between 
the theoretical absorbance of a mixture of CNT and LDH and the absorbance experimentally 
measured (Figure 4).  
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 Figure 6: Adsorption isotherm of LDH on CNT for different LDH concentrations. Results 
are reported by mass (in µg) of CNT. 
 
 Modeling of the adsorption of LDH on CNT: 
The adsorption of proteins on a surface are usually modeled using the Langmuir model. It 
initially modeled the reversible adsorption of a gas molecules monolayer on a surface. The 
following equation gives the mathematical model for the adsorption of a protein on a 
surface: 
     
              
             
 
Equation 3 
 
where nads corresponds to the amount of proteins adsorbed by mass of solid, neq the maximal 
amount of proteins adsorbed by mass of solid, Kads the adsorption constant, nfree the amount 
of free protein. 
Here, the equation is adapted to normalize the data by the mass of CNT: 
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Equation 4 
 
The equation is rearranged assuming that            . Consequently,       
 
    
 . 
By replacing this constant in the previous equation, the following expression of the 
Langmuir equation is obtained:  
    
    
 
   
    
   
     
    
    
     
    
 
Equation 5 
 
  and neq are determined using a linear regression:  
     
     
    
     
 
 
   
       
 
     
     
   
     
 
Equation 6 
 
From the plot, reported in Supplementary Figure 4, it was determined that 
 
   
     
 
        and  
 
   
       
        therefore 
   
     =0.07 and  =30.14. 
This fitted with the adsorption isotherm reported in Figure 6, as illustrated in Figure 7. 
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Figure 7: Adsorption isotherm of LDH on CNT fitting with the Langmuir model. 
 
Rigorously, it should be specified that although the Langmuir model proposed allows a 
satisfactory mathematical fit of the adsorption data, the basic assumptions of the model were 
not fully verified. Indeed, we did not check if all conditions implied in the Langmuir model 
were met (e.g. the reversibility of adsorption, the monolayer coverage, the site-binding model 
were not demonstrated). But the understanding of the adsorption mechanism was beyond 
the scope of this study and it was observed that our experimental data mathematically fitted 
best with the Langmuir model. Moreover, other models (Hasley, Temkin-Pyzhev, 
Freundlich) were tested but the results were not satisfactory as illustrated in Supplementary 
Figure 5. 
Finally, the actual concentration of LDH in solution can be calculated by combining the 
following equations: 
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 and keeping in mind that 
   
     was already calculated: 
     
             
      
  
    
 
    
                
        
 
    
                  
 Equation 7 
 
It is therefore possible to determine the actual LDH concentration in solution after the 
calculation of the adsorption constants as determined by a cell free assay. 
 
 Correction of data from cellular assays: 
This approach was adopted to correct results from previous experiments, in which 
macrophages from the RAW264.7 cell line were incubated with CNT for 24 hours and the 
LDH release was assessed using the same assay to detect the membrane integrity loss19. 
Figure 8 compares the values before and after correction. The differences ranged from 9 to 
12% depending on CNT concentration. Only the highest concentration of CNT triggered a 
LDH release significantly different from that of the control but the same conclusion was 
reached either with or without correction. Even though the correction did not change the 
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conclusion of the assay in this particular case, it clearly appeared that data were 
underestimated. Results are more accurate and trustable after correction. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 8: LDH release expressed as a percent of the positive control (lysed cells) determined 
after a 24h incubation of RAW264.7 macrophages with various concentrations of CNT. The 
white bar represents the negative control (cells incubated without CNT), grey bars represent 
the raw data from the assay and the black bars represent the results after correction of the 
bias due to the presence of CNT. * means significantly different from the negative control 
(p<0.05, Student test). 
 
Discussion:  
Current in vitro toxicity tests used for nanomaterial risk assessment rely on standard viability 
assays that were developed for chemicals or macro-scale substances and that are frequently 
based on absorbance or fluorescence measurements. However, nanomaterials display unique 
physicochemical properties that can interfere with or pose challenges to the use of classical 
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toxicity assays3,17. They can even lead to false-positive or false-negative results resulting 
subsequently in misinterpretations. Nanomaterial interferences with toxicity assays should 
not be neglected as they have been reported for most spectroscopic analyses6.  
Possible interactions from particles are: 1) particle optical properties that interfere with light 
absorption or fluorescence used for detection, 2) chemical reactions between the particles and 
assay compounds, and 3) adsorption of assay molecules to the particle surface3,17. 
In this study focused on the cytotoxicity of CNT as determined by the LDH release assay, we 
clearly demonstrated an optical artifact (due to the intrinsic absorbance of the CNT) resulting 
in an over-estimation of the LDH release as well as a chemical bias (due to the adsorbance of 
LDH on the CNT) leading to an under-estimation of the LDH release. Therefore in this 
particular case the two kinds of artifacts seem to compensate and the final result has a poor 
impact on the conclusion of the toxicological assay as illustrated by the comparison of the 
results before and after correction of the bias (Figure 8). But it may not be always the case 
and the interferences should not be neglected but on the contrary should be carefully 
considered. 
Our results are in agreement with those of Wang et al.20 who observed a decrease in the 
absorbance at 490 nm of LDH solutions with increasing CNT concentrations. Our 
observations are also concordant with those of Breznan at al.18 who, although using another 
detection system (the fluorescent resorufin), reported that CNT could decrease the 
fluorescence signal through optical interference. This effect was not surprising as CNT are 
highly optically dense materials that prevent transmitted/emitted light from reaching the 
detector as already reported by Oostingh et al.13. This quenching of fluorescence by CNT was 
also reported by others9,10 whereas other nanomaterials such as quantum dots or C60 
fullerene did not interact with the resorufin fluorimetric assays18. Alternatively (and 
sometimes additionally) the bias could originate from a physical interaction between the 
fluorescent/colorimetric dye and the CNT. Indeed, it is now well admitted that 
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nanomaterials, due to their large surface area, can physically adsorb the assay components 
(e.g. substrates, dyes…) or the molecule to dose17,21. In this case, nanomaterial characteristics 
(such as hydrophobicity, surface charge…) are expected to play an important role in the 
adsorption process5,17.  
The lack of sensitivity and reliability of existing methods clearly argue for the urgent need 
for the development of alternative and validated assays, best adapted to nanomaterial 
specificities as supported by many authors3,5,9,15,17,20,21 or as demonstrated by international 
efforts to discuss and determine which protocols might be standardized15. Recently, some 
new methods and modified versions of pre-existing methods have been developed for 
assessing the toxicity of nanomaterials3. One strategy may be to limit the interferences. To 
that purpose, Ali-Boucetta et al.22 have chosen to assess the intracellular LDH instead of the 
extracellular LDH to avoid the interactions between CNT and the components used in the 
test. After incubation with cells, CNT are rinsed off from the supernatant and the impact on 
the absorbance measure should therefore be eliminated. Cells are then lysed, centrifuged, 
and the amount of LDH present in the supernatant is determined reflecting the relative 
amount of viable cells instead of the amount of damaged cells as determined with the 
classical LDH assay. However, this approach has some limitations for instance it is difficult 
to rinse off all CNT, some remaining attached to cell membranes and some potentially 
uptaken in the cytoplasm10,17. It may therefore be technically difficult to assess the bias and 
potentially not completely reliable. Moreover, particle induced artifacts are still 
controversial, especially they are thought to depend on the type of CNT considered. This is 
why the systematic consideration of the interferences in the CNT cytotoxicity assays remains 
rare6. 
Another way to mitigate the interactions between nanomaterials and CNT consists in 
limiting nanomaterials concentrations below levels that interfere or by adding compounds 
such as FBS which can decrease the adsorption of cytokines to particles17. 
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As an example of alternative method, Wang et al.20 propose a variant in the LDH assay, they 
recommend to measure absorbance at 580 nm instead of 490 nm, as they observed that while 
the broad 490 nm absorbance peak was decreased in intensity with increasing CNT 
concentrations, the smaller absorbance peak at 580 nm also varied, but considerably less. 
Although reducing the bias, this solution remains imperfect as it does not eliminate the 
interferences. 
Until methods that avoid nanoparticle interferences have been fully developed, it appears 
necessary to be very cautious when using usual cytotoxicity assays not specifically designed 
for nanomaterials. One should be aware of their limitations and should try to understand 
how nanomaterials might interfere in the toxicological assay and if it is possible should 
quantify these biases. Indeed, if the interference is well characterized for the exposure 
conditions, a correction factor may be applied to the results15,17. To that purpose the 
evaluation of adsorption isotherms may be useful. But, it should be kept in mind that the 
adsorption of LDH on CNT is very likely to depend on the CNT physico-chemical features, 
especially the structural defect rate and the surface chemistry. Thus, adsorption isotherms 
should be calculated for each type of CNT.  
To summarize, most researchers are now aware of the nanomaterial interference issue and 
many of them have emitted recommendations:  
 the compatibility of an assay must be verified for each type of nanomaterial, in other 
words, it must be checked that the nanoparticles under investigation do not interfere 
with a specific assay at the expected concentrations. And to that purpose relevant 
controls must be used3,6–8,15,17,20,21. 
 if interferences are found to occur with an assay and if alternative systems are not 
available the interferences should be limited (for example by using low concentrations of 
nanomaterials as the highest the concentration, the greater probability of interferences). 
Alternatively, interferences should be carefully characterized to be taken into account. 
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Artifacts should be quantitatively evaluated and a corrective factor may be applied to the 
data6,17,18,20,21.   
 two or more independent test systems should be performed to validate the results before 
concluding on the nanomaterial toxicity3,5,7,21. 
 new or adapted methods must be developed to get new standards for nanoparticle risk 
assessment5. 
 
Conclusion:  
Interferences occur in the LDH assay due to the intrinsic absorbance of CNT on one hand 
and to the adsorption of LDH at the CNT surface on the other hand. Even if the final artifacts 
are low, a correction is necessary to be rigorous. Further investigations with other kinds of 
nanomaterials are required to better understand this phenomenon and to adapt the 
correction to each case.  
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Supporting information available. 
Five supplementary figures illustrate respectively: 1) the standard curve of absorbance at 450 
nm of LDH solutions depending on the LDH concentration, 2) the absorbance of solutions 
containing CNT and LDH depending on the CNT concentration, 3) the adsorption isotherm 
of LDH on CNT for different concentrations of LDH reported by surface of CNT, 4) the linear 
regression for the determination of the parameters of the Langmuir model and 5) the 
adsorption isotherm of LDH on CNT with the Hasley, Temkin-Pyzhev and Freundlich 
models. 
This material is available free of charge via the Internet at http://pubs.acs.org.   
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Supplementary Figure 1: Standard curve of absorbance at 450 nm of LDH solutions 
depending on the LDH concentration (without CNT).  
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Supplementary Figure 2: Absorbance of solutions containing CNT and LDH depending on 
the CNT concentration. 
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Supplementary Figure 3:  Adsorption isotherm of LDH on CNT for different concentrations 
of LDH. Results are reported by surface (in m²) of CNT. 
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Supplementary Figure 4:  Linear regression for the determination of the parameters of the 
Langmuir model. 
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Supplementary Figure 5: Adsorption isotherm of LDH on CNT with the Hasley, Temkin-
Pyzhev and Freundlich models. 
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